Artemisinic Acid Market (2026 - 2033)

Artemisinic Acid Market Summary

The global artemisinic acid market size was valued at USD 790.0 million in 2025 and is projected to grow from USD 821.6 million in 2026 to USD 1,079.0 million in 2033, at a CAGR of 4.0% from 2026 to 2033. Middle East & Africa dominated the global market, accounting for the largest revenue share of 57.0%% in 2025. This growth can be attributed to the high incidence of malaria, especially in developing and underdeveloped economies; initiatives by public organizations to raise awareness of malaria treatment; and increased research into malaria treatment, which are expected to drive the market over the forecast period.

Malaria is a life-threatening disease. According to the World Health Organization (WHO), there were approximately 282 million cases and 610 000 malaria fatalities worldwide in 2024. This high disease burden is expected to increase demand for new treatment options and create opportunities for artemisinin-based therapies.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Public organizations across the globe have taken initiatives to improve access to effective malaria treatment and reduce deaths associated with the disease. For instance, in December 2024, the World Health Organization (WHO) published the World Malaria Report 2024, highlighting the need to expand access to malaria prevention, diagnosis, and treatment services to accelerate progress toward global malaria reduction targets, particularly in high-burden countries. Such initiatives by public organizations to provide treatment at low cost are expected to increase demand for treatments such as artemisinin acid, thereby supporting market growth.

In endemic countries around the globe, artemisinin-based combination therapies (ACT) are currently used as the first line of malaria treatment. Artemisinin is made by synthesizing artemisinic acid. The high use of Artemisinin and the cost-effectiveness of Artemisinin prepared from artemisinic acid are expected to drive demand for artemisinic acid production for treating malaria. This is also expected to improve its adoption, especially in endemic countries, thereby supporting market growth. 

Market Dynamics

The industry is expanding steadily, driven by rising global demand for artemisinin-based combination therapies (ACTs) and the growing emphasis on plant-derived pharmaceutical intermediates. Increasing incidences of malaria in endemic regions, combined with sustained efforts by international health organizations and national governments to expand access to ACTs, are reinforcing demand for artemisinic acid as a critical biosynthetic precursor. The growing adoption of synthetic biology and microbial fermentation technologies is further transforming production scalability and cost efficiency, strengthening the market's long-term supply outlook.

Analyst Perspective

The artemisinin market is witnessing stable growth, driven by the continued global burden of malaria and rising demand for artemisinin-based combination therapies (ACTs). Increasing investments in malaria control programs and advancements in semi-synthetic production technologies are improving supply reliability and market growth. Despite challenges such as raw material dependence and regulatory requirements, sustained efforts to eliminate malaria are expected to support long-term market expansion, particularly in endemic regions.

Type Insights

Based on type, the antimalarial tablets segment led the market with the largest revenue share of over 80.0% in 2025and is also expected to grow at the fastest CAGR over the forecast period. Tablets are an oral way of drug administration. Tablets are self-administering and do not require a trained physician for drug administration, which is one of the major reasons for the high acceptance of tablet formulations. Moreover, tablet formulations offer high patient compliance, accurate dosing, control of drug release, and stability. This further improves the demand for antimalarial tablet formulations in the market. In addition, the widespread use of artemisinin-based combination therapies (ACTs) in tablet form as the standard treatment for uncomplicated malaria is further supporting segment growth.

The antimalarial injection segment is expected to witness a considerable growth rate over the forecast period. Antimalarial injections are used for severe malaria cases, especially during the time of emergencies. The high bioavailability of injectable formulations, which leads to immediate onset of action, is the primary factor driving demand in the market. The high number of hospitalizations due to malaria worldwide is expected to further boost the segment's market growth. In addition, increasing government efforts to improve access to lifesaving malaria treatments in hospitals and emergency care settings are supporting the adoption of injectable antimalarial therapies.

Regional Insights

Middle East & Africa artemisinic acid market held the largest share of around 57.0% in 2025 and is also expected to grow at the fastest CAGR of over 4.0% over the forecast period. Africa is one of the major countries which suffers significantly from malaria. For instance, UNICEF reports that every minute a child under 5 years dies from malaria in Africa. In MEA, public organizations are keen to provide treatment to reduce the number of deaths associated with the disease.

To learn more about this report, Download Free Sample Report

According to the WHO's World Malaria Report 2024, the WHO African Region accounted for approximately 94% of global malaria cases and 95% of malaria-related deaths in 2023. The continued concentration of the disease burden across African countries has prompted governments, international health agencies, and donor organizations to strengthen malaria prevention, diagnosis, and treatment programs. The high prevalence of malaria and sustained investments in antimalarial interventions are supporting the growth of the regional market.

Asia Pacific Artemisinic Acid Market Trends

The artemisinic acid market in Asia Pacific accounted for the second-largest share in 2025. Countries such as India, Pakistan, Indonesia, and others suffer from a high burden of malaria cases in the region. India is known for the world's third-highest malaria burden. The initiatives taken by public organizations in APAC countries to reduce the burden of malaria and ensure proper treatment are expected to boost the market in the Asia Pacific. For instance, in 2024, the Government of India launched the National Strategic Plan for Malaria Elimination (2023-2027), which focuses on enhanced surveillance, universal access to diagnosis and treatment, and a Test, Treat, and Track approach, aiming to achieve zero indigenous malaria cases by 2027.

Key Artemisinic Acid Company Insights

Market players are undertaking various strategic initiatives, such as launching new products, entering into partnerships, and pursuing mergers and acquisitions, to strengthen their product portfolios and gain a competitive advantage. For instance, dōTERRA announced four new wellness innovations during its Global Convention, including RevitaZen+ Advanced Organ Detoxification Complex. The launch expanded the company's portfolio of botanical and essential oil-based wellness products and reinforced its focus on product innovation in the natural wellness space.

Key Aromatherapy Carrier Oil Companies

Some of the key players operating in the artemisinic acid market are:

• Sanofi

• KPC Pharmaceuticals, Inc

• Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

• Calyx Chemicals and Pharmaceuticals Ltd.

• Novartis AG

• Ipca Laboratories Ltd.

• Cipla.

• SHINPOONG.CO,.LTD

• Hostinger

• AdvaCare Pharma

Recent Developments

• In May 2025, a paper published by the National Library of Medicine outlines the integration of supercritical CO₂ extraction from the Artemisia annua plant. This is expected to enhance microbial fermentation, thereby improving overall production efficiency and purity.

• In April 2025, a paper from the National Library of Medicine identified and engineered dihydroartemisinic acid dehydrogenase (AaDHAADH) enzyme. This enzyme enables direct, bidirectional conversion between artemisinic acid and dihydroartemisinic acid. This will help boost yields in engineered yeast.

Global Artemisinic Acid Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artemisinic acid market report on the basis of type and region

To learn more about this report, Download Free Sample Report

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Antimalarial Injections

  • Antimalarial Tablets

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Thailand

    • Australia

    • Pakistan

    • Indonesia

    • Vietnam

  • Central & South America

    • Mexico

    • Argentina

    • Colombia

    • Brazil

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

    • Nigeria

    • Democratic Republic of Congo

    • Mali

    • Uganda

    • Kenya